Lexicon Pharmaceuticals, Inc.

NASDAQ (USD): Lexicon Pharmaceuticals, Inc. (LXRX)

Last Price

0.76

Today's Change

+0.033 (4.53%)

Day's Change

0.72 - 0.802

Trading Volume

3,281,215

Overview

Market Cap

274 Million

Shares Outstanding

361 Million

Avg Volume

4,942,273

Avg Price (50 Days)

0.79

Avg Price (200 Days)

1.49

PE Ratio

-1.07

EPS

-0.71

Earnings Announcement

10-Mar-2025

Previous Close

0.73

Open

0.72

Day's Range

0.72 - 0.8019

Year Range

0.62 - 3.73

Trading Volume

3,281,215

Price Change Highlight

1 Day Change

4.50%

5 Day Change

-8.80%

1 Month Change

-3.61%

3 Month Change

-37.18%

6 Month Change

-55.29%

Ytd Change

-2.19%

1 Year Change

-62.92%

3 Year Change

-75.00%

5 Year Change

-75.87%

10 Year Change

-87.80%

Max Change

-99.42%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment